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Summary
Williams-Beuren syndrome (WBS) is a developmental
disorder caused by haploinsufficiency for genes in a 2-
cM region of chromosome band 7q11.23. With the ex-
ception of vascular stenoses due to deletion of the elastin
gene, the various features of WBS have not yet been
attributed to specific genes. Although 16 genes have
been identified within the WBS deletion, completion of
a physical map of the region has been difficult because
of the large duplicated regions flanking the deletion. We
present a physical map of the WBS deletion and flanking
regions, based on assembly of a bacterial artificial chro-
mosome/P1-derived artificial chromosome contig, anal-
ysis of high-throughput genome-sequence data, and
long-range restriction mapping of genomic and cloned
DNA by pulsed-field gel electrophoresis. Our map en-
compasses 3 Mb, including 1.6 Mb within the deletion.
Two large duplicons, flanking the deletion, of 320 kb
contain unique sequence elements from the internal bor-
der regions of the deletion, such as sequences from
GTF2I (telomeric) and FKBP6 (centromeric). A third
copy of this duplicon exists in inverted orientation distal
to the telomeric flanking one. These duplicons show
stronger sequence conservation with regard to each
other than to the presumptive ancestral loci within the
common deletion region. Sequence elements originating
from beyond 7q11.23 are also present in these duplicons.
Although the duplicons are not present in mice, the order
of the single-copy genes in the conserved syntenic region
of mouse chromosome 5 is inverted relative to the hu-
man map. A model is presented for a mechanism of
WBS-deletion formation, based on the orientation of
duplicons’ components relative to each other and to the
ancestral elements within the deletion region.
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Introduction
Williams-Beuren syndrome (WBS [MIM 194050]) is
caused by a submicroscopic deletion of band 7q11.23
(Ewart et al. 1993; Francke 1999). Identification of pa-
tients with single-gene defects has confirmed that hap-
loinsufficiency for the elastin (ELN) gene is responsible
for vascular pathology—and, possibly, for bladder and
intestinal diverticuli—but has no clear relation to the
other connective-tissue problems of WBS, including in-
guinal hernias, contractures of the joints, some of the
characteristic facial features, and premature aging of
the skin (Ewart et al. 1993; Li et al. 1997; Tassabehji
et al. 1997). Other phenotypic features of WBS include
growth retardation, renal anomalies, transient hyper-
calcemia, hyperacusis, anxiety disorder, attention-deficit/
hyperactivity disorder, and mental retardation (Pober
and Dykens 1996; Kaplan et al., in press). To date, the
specific genes within the deletion to which these effects
are attributable have not been identified. The pattern of
cognitive dysfunction in WBS is characterized by pro-
nounced difficulty with processing of visual-spatial in-
formation and relative preservation of linguistic ability
(Dilts et al. 1990; Wang and Bellugi 1993; Wang et al.
1995; Karmiloff-Smith et al. 1997). The contribution of
deletion of LIM-kinase 1 (LIMK1) to the visual-spatial
learning difficulty is not yet clear. Evidence for (Fran-
giskakis et al. 1996) or against (Tassabehji et al. 1999)
this hypothesis has rested on the ascertainment of par-
tial-deletion families whose phenotype specifically in-
cludes or excludes the “WBS cognitive profile.”
A common WBS-deletion region, estimated at 2 cM,
was defined by the genotyping of multiple affected in-
dividuals for microsatellite markers from 7q11.23
(Pe´rez-Jurado et al. 1996; Wu et al. 1998). The physical
size of the deletion was predicted to be ∼2 Mb, on the
basis of the genetic map and the fact that it is visible on
high-resolution chromosomes (Pe´rez-Jurado et al. 1996;
Francke 1999). Osborne et al. (1997a, 1997b, 1999)
provided an incomplete physical map based on assembly
of a P1-derived artificial chromosome (PAC)/cosmid
contig that included 1.1 Mb fully contained within the
deletion. Restriction mapping of similar bacterial arti-
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ficial chromosome (BAC)/PAC clone contigs by two in-
dependent groups estimated the common deletion as be-
ing 1.5 Mb (Meng et al. 1998a) or 1.4 Mb (Hockenhull
et al. 1999).
Genes identified within the common WBS deletion in-
clude a human homologue of the Drosophila frizzled
receptor (FZD9 [Wang et al. 1997]); syntaxin 1A
(STX1A [Osborne et al. 1997b]); CYLN2/CLIP-115, en-
coding an intracellular linkage protein (De Zeeuw et al.
1997; Hoogenraad et al. 1998) that covers the partial
transcripts WSCR3 and WSCR4 (identified by Osborne
et al. 1996); EIF4H, a translation-initiation factor (Rich-
ter-Cook et al. 1998) covering the partial transcript
WSCR1 (also identified by Osborne et al. 1996); GTF2I,
encoding the transcription factor TFII-I/SPIN/BAP-135
(Pe´rez-Jurado et al. 1998); replication factor–complex
C subunit 2 (RFC2 [Osborne et al. 1996; Peoples et al.
1996]); FKBP6, an immunophilin FK-506–binding pro-
tein–family member (Meng et al. 1998b); BCL7B, a se-
quence related to a gene identified from a Burkitts lym-
phoma translocation cell line (Jadayel et al. 1998; Meng
et al. 1998b); TBL2/WS-ßTRP, a member of the beta-
transducin gene family (Meng et al. 1998b; Pe´rez-Jurado
et al. 1999); a gene, preliminarily named “WS-bHLH,”
for the presence of a helix-loop-helix motif (Meng et al.
1998a); WBSCR9/WSTF, a large transcript encoding a
putative transcriptional coactivator (Lu et al. 1998; Peo-
ples et al. 1998); CPETR1 and CPETR2, named for their
pathological function as Clostridium perfringens–en-
terotoxin receptors that belong to the claudin family of
tight-junction proteins (Paperna et al. 1998); a putative
transcription-factor gene with GTF2I-related repeats,
GTF2IRD1 (Franke et al. 1999; Osborne et al. 1999);
and two incompletely characterized transcripts, desig-
nated “WBSCR2” and “WBSCR5” (Osborne et al.
1996).
The WBS-deletion region is flanked by highly con-
served duplicated elements within which the common
breakpoints cluster. Homologous recombination be-
tween these nearly identical regions is believed to ac-
count for the high incidence of de novo deletion for-
mation. Genotyping of flanking markers in informative
extended families has revealed that deletions arise from
interchromosomal recombination events in approxi-
mately two-thirds of cases and from intrachromosomal
events in approximately one-third of cases (Dutly and
Schinzel 1996; Baumer et al. 1998). The flanking du-
plications were first identified by studies of the micro-
satellite marker D7S489, primers for which amplify al-
leles that cluster in three different size ranges,
corresponding to three distinct polymorphic loci
(D7S489A, -B, and -C [Pe´rez-Jurado et al. 1996; Rob-
inson et al. 1996]). The upper (D7S489B, 170–178 bp)
and lower (D7S489A, 140–144 bp) loci map near the
proximal and distal boundaries of the deletion, the for-
mer falling within the deletion and the latter outside the
deletion. D7S489C-sized alleles (156–158 bp) have been
mapped to a poorly defined locus just outside the de-
letion region, variably placed on the centromeric (Pe´rez-
Jurado et al. 1996; Osborne et al. 1997a) or telomeric
(Robinson et al. 1996) side. Subsequently, Pe´rez-Jurado
et al. (1998) identified the GTF2I gene in the telomeric,
and the GTF2IP1 pseudogene in the centromeric, break-
point regions. Whereas the 5′ unique region of GTF2I
extends into the deletion, the pseudogene is centromeric
to the common breakpoints.
Evidence for a third GTF2I locus outside but very
close to the deletion has been emerging. The map pub-
lished by Osborne et al. (1997a) placed two copies of a
GTF2I-like sequence at the centromeric, and one at the
telomeric, breakpoint regions, each copy in association
with a PMS2-like gene (PMS2L). By using FISH, they
showed that the PMS2L genes map to the three sites
within 7q11.23 and to another locus at 7q22, as well.
Go¨rlach et al. (1997) described the p47-phox gene
(NCF1) and pseudogene (NCF1P1) and provided evi-
dence for a second copy of the pseudogene at an un-
known locus. The map published by Hockenhull et al.
(1999) includes two GTF2I/NCF1 duplications, one
each at the centromeric and telomeric breakpoint
regions; furthermore, typing of a YAC disclosed the pres-
ence of another NCF1 pseudogene somewhere near the
telomeric duplication.
Recently, DeSilva et al. (1999) used FISH with du-
plicated-region clones and found the duplications to be
present in nonhuman primates, including chimpanzees,
gorillas, orangutans, and gibbons. As in humans, hy-
bridization signals were also detected at 7q22 and 7p22
in chimpanzees and gorillas but not at the homologous
sites in gibbons and orangutans. Relative to the human
sequence, chromosomes underwent peri- and paracentric
inversions between the 7q11.23-q21 region and 7q22 in
the gorilla or 7p22 in the orangutan. In mice, only a
single site was present, consistent with the finding that
Gtf2i is a single-copy gene in the mouse (Wang et al.
1998b).
We have constructed a physical map of the WBS de-
letion by assembling a BAC/PAC clone contig and by
restriction mapping of clones and of genomic DNA from
normal and WBS deletion–carrying human chromo-
somes 7. Our estimate of the common deletion size is
1.5–1.7Mb. The deletion region is flanked by two highly
homologous duplicons of 320–500 kb. These duplicons
are a patchwork of at least four definable repeats that
are present, in different orientations, within the dupli-
cons. Each repeat is composed of stretches of DNA with
high homology in coding and noncoding sequences. We
have adopted the term “duplicon” to designate these
large genomic regions. This term, first proposed by Ei-
chler et al. (1997), was recently used by Christian et al.
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(1999) for similar observations in the region flanking
the Prader-Willi syndrome/Angelman syndrome–dele-
tion region on chromosome 15. We propose an evolu-
tionary model for the complex organization by serial
duplications of ancestral elements, some of which are
located within band 7q11.23 and others of which are
elsewhere on chromosome 7.
Material and Methods
Samples and DNA Isolation
Human genomic DNA was obtained from subjects
with WBS who had the common deletion, from their
parents, and from normal controls, under institutional
review board–approved protocols. Clinical criteria for
inclusion within this study and deletion characterization
have been described elsewhere (Pe´rez-Jurado et al.
1996). DNA was isolated from peripheral blood lym-
phocytes or Epstein-Barr virus–immortalized lympho-
blastoid cell lines (LCLs), either in solution or as intact
chromosomes imbedded in agarose blocks, for pulsed-
field gel electrophoresis (PFGE; see below). Fusion of
fresh leukocytes from a subject with WBS and a Chinese
hamster fibroblast line generated two hybrid lines re-
taining WBS-deletion chromosome 7 (SCH DEL-1 and
SCH DEL-2, previously called “53-7” and “53-13”
[Peoples et al. 1996]) and two hybrid lines retaining the
normal chromosome 7 (SCH NONDEL-1 and SCH
NONDEL-2, previously called “53-8” and “53-15”).
BAC-Library Screening
A human genomic BAC library (Kim et al. 1996) was
screened by PCR assay of plate pools obtained from
Research Genetics (release IV). Forty-seven clones iden-
tified were purchased as agar stabs, and DNA was iso-
lated by use of QiagenMaxiprep reagents and amodified
low-copy plasmid–preparation protocol. Three PAC
clones (Ioannou et al. 1994) were purchased from Re-
search Genetics. For sequence-tagged site (STS) content
mapping, PCR amplifications were carried out in 25-ml
reactions with 1.5 mM MgCl2, and either 10–20 ng of
clone DNA or 50–100 ng of genomic DNA, for 35 cycles
of 94C for 30 s, 55C for 30 s, and 72C for 45 s, in
an MJ PTC-200 thermocycler.
STS Generation
Primer sequences for STS markers used in this study
are given in table 1. Primer sequences for some STS
markers were taken from the Human Chromosome 7
Mapping and Sequencing Web site (Bouffard et al.
1997); the Stanford Human Genome Center RH-map-
ping web site (Stewart et al. 1997); and the STS-Based
Map of the Human Genome Web site, release 12, July
1997 (Hudson et al. 1995). D7S489 amplimers were
sized by GeneScan analysis, as described elsewhere (Peo-
ples et al. 1998).
Original STSs were generated from analysis of either
clone sequence or GenBank sequence, with either the
program PRIMER 0.5 (Whitehead Institute 1991) or
OLIGO 5.1 (National Biosciences). To develop new
STSs, sequences from BAC and PAC ends were obtained
either by direct sequencing (Peoples et al. 1998) or by
a modified vectorette-PCR protocol (Riley et al. 1990).
For the latter, primer sequences (5′r3′) were R1 (CTC-
GTATGTTGTGTGGAATGTGAGC), R2 (TTTCAC-
ACAGGAAACAGCTATGACCATG), L1 (GGGTTT-
TCCCAGTCACGACG), and L2 (GTCGACCTGCAG-
GCATGCAA); enzymes for BAC digestion were BsaAI,
BstUI, and a combination of EcoRV, PvuII, StuI, and
XmnI. Direct sequencing of amplimers was performed
by use of the L2 and R2 primers, as described elsewhere
(Peoples et al. 1998). The PAC end sequence 953F13R
was derived by direct sequencing by use of the primer
(5′r3′) CCGTCGACATTTAGGTGACAC. Markers
763H7L, 763H7R, 965F7L, 797L, and 17SP were de-
rived, by vectorette PCR (Riley et al. 1990), from the
left and right arms of CEPH YACs 763H7 and 965F7
(Dausset et al. 1992; Hudson et al. 1995), the left arm
of YAC HSC7E797 (Kunz et al. 1994), and the SP arm
of P1 clone RMC1317 (Shepherd et al. 1994), identified
by screening for the D7S489C locus. GenBank accession
numbers for all sequences are listed in table 1.
Hybridization Probes
Probes for PFGE hybridization experiments were ei-
ther intact cDNA clones without prior separation of in-
sert or gel-purified PCR products (Wizard PCR Preps),
except as noted. In the former case, unless otherwise
cited, IMAGE-consortium cDNA clones were obtained
from Research Genetics, and DNA was isolated by use
of a Qiagen miniprep protocol. Specific probe infor-
mation is given in table 2.
High-Throughput Genome-Sequence (HTGS) Data
Analysis
BACs for which HTGS data were available were iden-
tified by a BLAST 2.0 alignment search (Altschul et al.
1990, 1997) of the HTGS database maintained by
NCBI, with selected STS sequences used as probes (Ouel-
lette and Boguski 1997; Sulston and Waterston 1998).
Genomic sequence information was obtained from the
Genome Sequencing Center database, Washington Uni-
versity (St. Louis), except for 239C10, which was ob-
tained from GenBank (table 3). Comparison between
the sequence of HTGS clone and STS sequences was
performed with Sequencher 3.0 alignment software
(GeneCodes), at 85% homology. All STS data are avail-
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Table 2
Hybridization Probes for PFGE Blots
Probe Clone
Size
(bp)a
GenBank
Accession
Number Reference
17SP P1 clone RMC1317 (Colin Collins, UCSF/LBL), SP vectorette product 900 Present study
CPETR1 cDNA clone ? R48300 Paperna et al. (1998)
CPETR1 cDNA clone ? W74492 Paperna et al. (1998)
ELN cDNA clone containing ELN ORF (Joel Rosenbloom, U. Pennsylvania) 2,200 U62292 Present study
FZD9 cDNA clone containing FZD9 ORF 2,200 NM_003508 Wang et al. (1997)
GTF2I cDNA clone 86072 (IB291) (ATCC) 1,500 T03439 Perez-Jurado et al. (1998)
GTF2IRD1 cDNA clone hbc694 (exon 24) (Graeme Bell, U. Chicago) ? T10636 Franke et al. (1999)
IB2070 cDNA clone ? R20285 Present study
POM121 cDNA clone ? R87509 Present study
RFC2 cosmid RFCp40-#3, T7 vectorette product 1,900 AF045555 Peoples et al. (1996)
SHGC-31781 cDNA clone ? R52511 Present study
STAG3L cDNA clone IB1445 (ATCC), 5′ end Alu/vector product 900 T03379 Present study
TBL2 cDNA clone C-0td07 ? Z42768 Perez-Jurado et al. (1999)
WSCR5
cDNA clone 52119, HindIII fragment
1,400 H23535 Present study
AMPLIMERS
(5′r3′)
Forward Reverse
CPETR2 TATGGAGCCGAGCCGTTAGC CGGATAATGGTGTTGGCC 600 AF007189 Paperna et al. (1998)
CYLN2 (EX3) CAGAGCCGCTGTCTGAGAG CCCCACTGCACAAACAGTC 530 AJ228871 Present study
ELN GCTTGCAGATCCACAGGGCAAG GCGAATCCAGCTTTGAGGCTTCA 368 U63721 Wedemeyer et al. (1997)
GTF2I-5′ ATGTCCACCCTCCCCGTTGA GGTGGCTTCCTTGAATGTTA 800 AF035737 Perez-Jurado et al. (1998)
HIP1 Same as STS in table 1 465 Y09420 Wedemeyer et al. (1997)
NCF1 (EX 2) CACACAGCAAAGCCTCTTTG TTCTGGGTTCTGCAGTTTCC 240 M25665 Present study
POM121-ZP3 TCACTCTTTAAAGGGTTGAGGG TGCTATATTTCCCCTACATGCC 722 U10099 Present study
STX1A (EX 6) Same as STS in table 1 299 U87315 Present study
WBSCR9 ATGACTTTGTTGGATATGGC CTTTCCGTTCTTCAGAC 322 AF084479 Peoples et al. (1998)
ZP3 CCCCAGCCTTAGAAACAGC TGGATGGAGACCACTTTATGC 802 X56777 Present study
a A question mark (?) indicates unknown.
Table 3
BACs Used for HTGS
Clone
GenBank
Accession
Number
239C10 AC004166
hDJ0665P05 AC004851
hDJ0771P04 AC004883
hDJ0953A04 AC006014
hDJ1158B01 AC004980
hGS166C05 AC004851
hNH0313P13 AC005488
hNH0340A14 AC007078
hNH0396K03 AC006995
hNH0479C13 AC005236
hRG023I15 AC005049
hRG051J22 AC005056
hRG052H06 AC005057
hRG208H19 AC005074
hRG269P13 AC005080
hRG270D13 AC005081
hRG315H11 AC005089
hRG350L10 AC005098
able from GenBank (table 1). Table 4 lists sequences
from GenBank that are used for comparisons.
Site-Specific Nucleotide (SSN) Assays of BACs
Covering Duplicons
PCR primers for STS markers containing SSNs are
given in table 1. STS marker GTF2I-ex19–20 PCR con-
tains the codon-changing nucleotide 2217 site difference,
and GTF2I-ex28 the silent nucleotide 3130 site differ-
ence, for the gene and pseudogene (Pe´rez-Jurado et al.
1998); the 303/305-bp NCF1–exon 2 containing a GT-
dinucleotide deletion of the pseudogene was described
by Go¨rlach et al. (1997). Assessment of presence or
absence of the PstI and TaqI restriction sites of the
NCF1–ex3-4 amplimers was performed by PCR amp-
lification of human, human # Chinese hamster so-
matic-cell hybrid DNA, hamster control DNA, and BAC
clone DNA, as described above, followed by restriction
digestion of products, in 50-ml volumes, with each of
these enzymes (New England Biolabs), followed by size-
fractionation on 2.5% agarose gels. PCR and digestion
conditions for assessment of the XcmI and SacII restric-
tion sites on 208H19M amplimers were the same as
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Table 4
Sequences from HTGS Database That Were Used for Comparisons
Sequence Nucleotides from GenBank Sequence
GenBank
Accession
Number Reference
23I15R 1–114 AF166287 Present study
51J24L 1–429 AF166305 Present study
93N13L 1–141 AF166320 Present study
194I16L 1–188 AF166284 Present study
194I16R 1–313 AF166285 Present study
350L10R 1–225 AF166299 Present study
426A23R 1–146 AF166302 Present study
435J21L 1–137 AF166303 Present study
537A20L 1–368 AF166307 Present study
CYLN2-ex15 10,6623–10,6826 AJ228878 Hoogenraad et al. (1998)
EIF4H 24,126–24,263, 24,554–24,693 AF045555 Osborne et al. (1996)
FKBP6-ex1-4 1–116, 117–162, 163–334, 335–537 NM_003602 Meng et al. 1998b
GTF2IP1-C 1–109 AF036613 Perez-Jurado et al. (1998)
GTF2I-ex2 416–689 AF035737 Perez-Jurado et al. (1998)
GTF2I-ex11 1259–1371 AF035737 Perez-Jurado et al. (1998)
PMS2L 46–187, 188–274, 275–377 U13696 Osborne et al. (1997a)
POM121-ex13 89,948–90,240 AC006014 Present study
STAG3L 41,849–49,348 AC006014 Present study
sWSS3380 1–150 G30694 Bouffard et al. (1997)
WS-bHLH 1,277–1,378, 1,875–2,026 AF056184 Meng et al. 1998a
ZP3-ex3 432–535 X56777 Kipersztok et al. (1995)
ZP3-ex7 924–1,060 X56777 Kipersztok et al. (1995)
those for NCF1–ex3-4. For all SSN markers, PCR was
carried out as above, in 50-ml volumes, by use of BAC-
clone DNA as template. DNA from these experiments
was gel purified and directly sequenced as described
above. Results of NCF1–ex3-4 and 208H19M digestion
were also verified by direct sequencing of PCR products
in this manner. SSN positions are given in table 5 and
in figure 4 and refer to the nucleotide number of the
corresponding GenBank entries.
PFGE
Agarose blocks were prepared from LCLs from the
donor of the SCH lines, 12 other sporadic WBS patients,
two sets of unaffected parents, 17 unrelated normal con-
trols, and human#Chinese hamster somatic-cell hybrid
lines immobilized in low-melting-temperature agarose,
at a concentration of ∼107 cells/ml. High-molecular-
weight DNA was prepared by incubation of agarose
blocks with sodium sarkosyl and proteinase K. After
having been washed in buffer, blocks were incubated
with the following restriction endonucleases (New Eng-
land Biolabs): NotI, PmeI, AscI, PacI, SfiI, BssHII,AvrII,
NheI, and SpeI. Digest products were size-fractionated
in either 1% (100-kb–1.6-Mb resolution) or 0.7% (1–5-
Mb resolution) agarose gel, by PFGEwith use of a CHEF
gel apparatus (Biorad) under the following conditions:
100–800-kb resolution at 10–50-s pulse times, 200 V,
24 h; 200-kb–1.5-Mb resolution at 40–150-s pulse
times, 200 V, 24 h; 2–4-Mb resolution at 1-h pulse time,
50 V, 120 h, followed by 90-s pulse time, 50 V, 24 h.
Undigested Saccharomyces cerevisiae, Schizosaccharo-
myces pombe, and Hansenula wingeii chromosomes
were used as size markers. Gels were imaged with eth-
idium bromide and were transferred to nylon filters by
use of the Southern blot technique. BAC and PAC DNA
in solution (see above) was digested with NotI, NotI/
PmeI, and NotI/AscI, in 30-ml volumes. Electrophoresis
was performed for 2–20-s pulse times at 200 V for 24
h in 1% agarose gels.
Probe labeling and hybridization techniques have been
described elsewhere (Peoples et al. 1998). Each probe
listed in table 2 was hybridized to a panel of blots con-
taining at least four WBS and four normal control sam-
ples, as well as the four hybrid cell lines described above.
Results
A 3-Mb Clone Contig and PFGE Map of the WBS
Deletion and Flanking Regions
To assemble a clone contig covering the ∼2-cM region
of the WBS deletion, we started with a YAC contig as-
signed to the flanking duplicated regions, as reported
elsewhere (Pe´rez-Jurado et al. 1996). Because the YACs
within the deletion appeared to be unstable and/or re-
arranged, we initiated a BAC library–screening effort. A
total of 58 markers, derived from gene sequences, public
databases, and YAC end sequences, were used in the
initial round of BAC-library screening (table 1). Order-
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ing of BACs, deepening of coverage, and closure of gaps
were accomplished through generation of new STSs de-
rived from BAC end sequences (table 1). An ∼500-kb
region between TBL2 and ELN was difficult to map and
appears to be underrepresented in the BAC library that
we used. This gap was closed by the serendipitous map-
ping of two new intradeletion genes within this region
(Paperna et al. 1998) and by incorporation of PAC
953F13 (Osborne et al. 1997a, 1997b) and PACs 632N4
and 391G2 (Meng et al. 1998a) into our contig. The
STS-content map of our clone contig, shown infigure 1,
covers the WBS deletion and both flanking regions.
HTGS data analyzed by sequence alignment were also
used in the construction of this map (table 3).
Long-range restriction mapping of contig clones and
genomic DNA provided a size estimate of 3 Mb for our
map of the deletion and flanking regions (fig. 2). The
deletion is covered by unique clones that are unambig-
uously ordered and that span a distance of 1.6 Mb (figs.
1 and 2). A gap remains in the telomeric flanking region
within the telomeric duplicon between clone 447M6 and
clones 163N16, 113E20, and 496I13 (figs. 1 and 2).
Comparison of PFGE data (table 5), obtained by use
of genomic versus clone DNA cleaved with three dif-
ferent enzymes and analyzed under a variety of electro-
phoretic conditions, resulted in excellent agreement. In
a few instances, the sizes of fragments generated by the
methylation-sensitive enzymes NotI and AscI were con-
sistent with CpGmethylation of genomic DNA sites that
were sensitive to digestion in the BACs and PACs. Pre-
sumptive methylation sites and the few restriction-site
discrepancies are indicated in figure 2.
Long-Range Restriction Mapping of Duplicons in the
Flanking Regions
In search of deletion junction fragments, we hybrid-
ized, with the GTF2I probe IB291, PFGE blots with
DNA from individuals with WBS, normal controls, and
WBS-deletion and nondeleted chromosome 7 somatic-
cell hybrids digested with SfiI, BssHII, AvrII, NheI, or
SpeI. For all enzymes and all samples, single restriction
fragments of 150 kb were seen. Conservation of re-
striction sites resulted in junction fragments identical in
size to the two fragments contributing to them. When
NotI fragments were separated under a range of con-
ditions, allowing effective resolution of fragments of 100
kb–5 Mb, a 4-Mb junction fragment was detected in
somatic-cell–hybrid lines containing the chromosome 7
with the WBS deletion (fig. 3A). Both NotI fragments
(1 and 3 Mb) derived from the normal chromosome 7
contribute to formation of the 4-Mb junction fragment
(fig. 3B). This conclusion was confirmedwhenNotI blots
were hybridized with single-copy probes mapping
outside the deletion, on opposite sides (fig. 3A). SHGC-
31781 from the telomeric side recognizes the 1-Mb frag-
ment, whereas IB2070 from the centromeric side
recognizes the 3-Mb fragment. The telomeric 5′-
GTF2I–specific probe from within the deletion (Pe´rez-
Jurado et al. 1998) also recognizes the 1-Mb fragment
(data not shown). The SHGC-31781 locus maps to the
telomeric YAC HSC7E640, whereas IB2070 maps to the
centromeric CEPH YAC 855H10 as mapped by Pe´rez-
Jurado et al. (1996). The size of the smaller fragment
was determined to be∼1Mb, on gels resolving fragments
of 200 kb–1.6 Mb; this fragment appears to run higher
on the 2–4-Mb-resolution gels shown here. The orien-
tation of the NotI fragments is shown in figure 3C. Hy-
bridization with a probe for the single-locus gene HIP1
shows that it also maps to the 1-Mb fragment (fig. 3A)
and is therefore on the telomeric side.
Inspection of the GTF2I/NotI PFGE hybridization
data suggested a twofold dosage of the 1-Mb fragment,
relative to the 3-Mb fragment (fig. 3B, bottom). Com-
parison with results obtained for the same blots hybrid-
ized with the POM121 probe (fig. 3B, top) confirm that
this is not an effect of less-efficient transfer of DNA for
the larger fragment relative to the smaller. Hybridiza-
tions, with the NCF1 probe, to filters of DNA cleaved
with NotI, PmeI, and AscI yielded the same results as
did hybridizations with the GTF2I probe. These results
suggested the presence of a third GTF2I/NCF1 locus
mapping outside the deletion to the same telomeric 1-
Mb NotI fragment involved in junction-fragment for-
mation as the original GTF2I/NCF1. The mechanism of
deletion formation appears to be consistent in WBS. As
shown in figure 3D, the same 4-Mb junction fragment
is present in seven unrelated individuals with WBS and
not in unaffected parents.
Identification of a Third GTF2I/NCF1 Locus
We began mapping the duplicons of the WBS deletion
and flanking regions by looking for single-nucleotide dif-
ferences that distinguish the GTF2I and NCF1 genes
from their pseudogenes. BACs 350L10 and 269P13were
assigned to the telomeric GTF2I/NCF1 locus and the
centromeric GTF2IP1/NCF1P1 locus, respectively, on
the basis of the three locus-specific single-nucleotide dif-
ferences in the GTF2I/GTF2IP1 3′ common region and
the 5′ GTF2I-specific region (Pe´rez-Jurado et al. 1998)
and the GT tandem repeat in exon 2 (Go¨rlach et al.
1997), which distinguishes NCF1 from the NCF1P1
pseudogene. BAC 239C10, for which HTGS data are
available, also contains the GTF2I and NCF1 genes, on
the basis of the presence of the same nucleotide variants
used to define 350L10. In turn, HTGS data for BAC
396K03 confirm that it contains the GTF2IP1 locus.
Surprisingly, the 136-bp GTF2IP1-specific 5′ exon se-
quence identified by Pe´rez-Jurado et al. (1998) was also
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Figure 3 NotI fragment analysis of the flanking and deletion-junction regions. A, 2–4-Mb resolution Southern blot of the four WBS SCH
lines, hybridized successively with flanking region probes. The probe for POM121, which is part of REP B, hybridized to both normal (3 and
1 Mb) NotI fragments and the 4-Mb junction fragment present only in the SCH DEL lanes. A probe for the telomeric locus SHGC-31781
hybridized to the lower fragment and to the junction fragment and thus localized the 1-Mb fragment to the telomeric side. The IB2070 probe
from the centromeric flanking region recognized only the upper fragment and the junction fragment, consistent with the 3-Mb NotI fragment’s
being derived from the centromeric side. The HIP1 locus, previously localized outside the WBS deletion (Wedemeyer et al. 1997), was localized
to the telomeric side, by hybridization to the 1-Mb fragment in the SCH NONDEL lanes and to the junction fragment in the SCH DEL lanes.
B, Southern blot of seven human normal control samples (NC), an SCH DEL line, and an SCH NONDEL line, hybridized successively with
probes for POM121 and GTF2I (IB291). Both probes recognized the 1- and 3-Mb bands flanking the deletion, as well as the 4-Mb deletion-
junction fragment. For POM121, differential hybridization intensities suggest a 2:1 copy-number ratio for the 3-Mb fragment, relative to the
1-Mb fragment, whereas for GTF2I the relative gene dosage is reversed. C, Map of the NotI fragments flanking the WBS deletion and of the
deletion-junction fragment. IB2070, SHGC-31781, and HIP1 are single-copy loci mapped to either the centromeric (IB2070) or the telomeric
(SHGC-31781 and HIP1) flanking region. GTF2I and POM121 exist in three copies. Both probes hybridize to the 4-Mb fragment with greater
intensity than do the single copy probes suggesting that two copies of these loci are flanking the deletion and that one is within the deletion.
D, PFGE Southern blots containing samples from affected (WS) individuals, parental controls (PAT and MAT), and unrelated normal controls
(NC), hybridized with either the POM121 or the GTF2I probes, documenting the consistency of the 4-Mb junction fragments in a larger number
of individuals with WBS. As in B, both probes recognize the 1- and 3-Mb NotI fragments in all samples. The 4-Mb fragment is seen with either
probe in all seven unrelated WS samples. The de novo occurrence of this deletion-junction fragment in case WS 1480 is illustrated by its absence
in both parents.
Peoples et al.: Physical Map of the WBS Deletion Region 59
Figure 4 A, Identification of the third GTF2I/NCF1 locus by
restriction digestion of the 392-bp amplimer of NCF1 exon 3–4 from
human cells, SCH, and BACs. These PCR products contain two SSN
differences that change restriction-enzyme sites: a PstI site at position
213 of the 350L10 amplimer (A at 213) is absent on 269P13 (G at
213), and a TaqI site at position 262 of 350L10 (C at 263) is also
absent on 269P13 (T at 263). Intact and digested PstI fragments were
generated from both the deleted and nondeleted SCH lines. Amplimers
of BACs 269P13 and 248G1 (GTF2IP1/NCF1P1) are not cut, whereas
those of BACs 350L10 and 102J16 (GTF2I/NCF1) and 447M6
(GTF2IP2/NCF1P2) are. In contrast, TaqI-cleaved bands were appar-
ent only in the SCH NONDEL-1 and -2 lanes, consistent with deletion
of the NCF1 locus residing on BACs 350L10 and 102J16(GTF2I/
NCF1), which also show TaqI digestion. Amplimers from BACs
269P13 and 248G1(GTF2IP1/NCF1P1) and BAC 447M6 (GTF2IP2/
NCF1P2) are not cut, consistent with their mapping to loci outside
the deletion. The combined TaqI and PstI data are consistent with a
model placing BAC 447M6 at a third NCF1 locus, outside the deletion.
Incomplete TaqI digestion of the BAC 102J16 amplimer does not affect
the conclusions, because the presence of a single locus with the TaqI
site has been confirmed by direct sequencing of the amplimer. B, As-
signment of BACs to repeat clusters by restriction digestion of human,
SCH, and BAC amplimers of the 479-bp STS 208H19M (in REP B1)
containing two SSN differences. Sequence comparisons revealed the
presence of an XcmI site at position 362 for the 208H19 amplimer
(CT at 366–367) and its absence on that for 313P13 (2-bp deletion,
relative to 208H19); in contrast, a SacII site was predicted at position
324 for 313P13 (T at 326) but not for 208H19 (G at 326). XcmI
restriction digestion generated, for BACs 23I15, 68E13, and 208H19,
predicted fragments of 330 and 150 bp that were absent in all other
BACs tested. Bands of the same size were also generated from the SCH
NONDEL lines but not from the SCH DEL lines. In contrast, SacII
yielded predicted bands of 300 and 180 bp only for BACs 194I16,
7H23, 163N16, and 34N24. In the case of SacII, uncut fragments
were of significantly lower intensity when they were from the SCH
DEL lines. These results provide strong evidence for the presence of
a locus on BACs 23I15, 68E13, and 208H19 within theWBS deletion,
a locus that is highly homologous to extradeletion sequences on BACs
194I16, 7H23, 34N24, 93N13, 496I13, 429B16, and 163N16.
present in BAC 239C10, establishing that this sequence
is not unique to the centromeric locus but, rather, is a
member of another duplicated element.
On the basis of sequence information from BACs
350L10 and 269P13, a 392-bp amplimer from intron 2
to intron 4 of the NCF1/NCF1P1 locus (NCF1–ex3-4)
was designed, incorporating four SSN differences, two
of which were discernible by restriction digestion. Re-
sults of restriction digestion of amplimers from theWBS-
deletion and nondeletion chromosome 7 SCHs and se-
lected clones from the duplicons are shown in figure 4A.
The presence of a PstI-sensitive amplimer in the SCHs
carrying the deleted chromosome 7, as well as the ab-
sence of TaqI sensitivity in these same amplimers, sug-
gests the presence of a third locus outside the deletion.
The digestion pattern of the amplimer from BAC 447M6
indicates that it maps to this site. Amplimers of all BACs
were sequenced and the results of the nucleotide differ-
ences defined three distinct sets, all entirely in agreement
with the results of the restriction digestions (table 6).
Comparison of the other GTF2I/GTF2IP1 and NCF1/
NCF1P1 amplimer sequences of these clones disclosed
that, for all other defined SSN differences, BAC 447M6
shares homology with the centromeric clones. The clones
from the duplicons were thus mapped to three loci that
are distinguishable by the SSNs present in the
NCF1–ex3-4 amplimer. The loci represented by clone
447M6 are henceforth referred to as “GTF2IP2” and
“NCF1P2.”
Presence of the unique-site STS SHGC-31781
(UniGene Hs.5291) unequivocally established contiguity
of BACs 447M6 and 435J21 (fig. 2). Another SSN assay
confirmed overlap of clone 435J21 with the GTF2I/
NCF1-containing clones 350L10, 102J16, 62H4, and
491N6 and with 239C10, by use of HTGS data. Results
of direct sequencing of amplimers of 269P13R (over-
lapping sWSS3499), including three SSNs predicted by
sequence comparison of HTGS data from BACs 313P13,
350L10, and 269P13 are shown in table 6. Because the
three duplicons represent paralogues, we defined the
term “paralotype” as the set of locus-specific nucleotides
identified by a given SSN assay. Presence of the para-
lotype GTA for amplimers, and/or HTGS data from each
of these clones, is evidence that these clones contain a
common 269P13R locus. Contiguity was thus provided
for the two GTF2I/NCF1 paralogues mapping to the
telomeric deletion–flanking region, in agreement with
the PFGE data.
The Flanking-Region Duplicons and Junction-Fragment
Formation
Extension of our contig by STS-content mapping of
clones contiguous with the GTF2I/NCF1 pseudogene
loci was hampered by the very high degree of sequence
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identity among them. PFGE data allowed mapping of
the duplicated elements prior to development of assays
that could discriminate among duplicons. Fragment sizes
for the nonunique probes POM121, STAG3L, and 17SP
are summarized in table 5. These probes were identified
as mapping to the flanking regions by STS-content map-
ping and HTGS-data analysis. POM121 sequences are
predicted to code for a 121-kD integral-membrane pro-
tein containing a nucleoporin-like region (Hallberg et al.
1993). STAG3L sequences show strong homology to the
Stromalin antigen 3 cDNA sequence (L. Pe´rez-Jurado,
personal communication), and 17SP is an anonymous
probe derived from P1 clone RMC1317. All three probes
mapped to two nearly identical sites flanking the deletion
contained on two 380-kb AscI fragments and on 210-
and 220-kb PmeI fragments. POM121 and 17SP also
mapped, within the deletion, to a 370-kb AscI fragment
in common with the intradeletion loci FZD9 and
WBSCR9 and with the centromeric GTF2IP1/NCF1P1
locus. STAG3L and 17SP also mapped to a third extra-
deletion locus, on the same 280-kb PmeI fragment as
SHGC-31781 mapped.
In the SCH-DEL lines, junction fragments for both
PmeI and AscI are recognized by the GTF2I probe.
Whereas the three GTF2I loci demonstrate near-
complete site conservation for PmeI, AscI sites differ-
entiate the loci. For PmeI, identically sized, 140-kb do-
nor fragments contribute to the 140-kb junction frag-
ment. AscI sites are found ∼100 kb centromeric of both
the GTF2IP1/NCF1/P1 locus and the GTF2I/NCF1 lo-
cus. Therefore, recombination between the 370-kb cen-
tromeric GTF2IP1/NCF1/P1-containing AscI fragment
and the 300-kb telomeric GTF2I/NCF1 fragment results
in a 300-kb AscI junction fragment nearly identical to
the GTF2I/NCF1-locus donor fragment. Deletion break-
points must occur at nearly homologous sites within or
near the centromeric GTF2IP1/NCF1P1 and telomeric
GTF2I/NCF1 duplications. Therefore, the common re-
combination event occurs between the centromeric du-
plicon GTF2IP1/NCF1P1 locus and the ancestralGTF2I/
NCF1 locus, which are in the same orientation.
Repeat (REP) Elements A–E
The PFGE data suggested a model in which two highly
homologous duplicons, each including one GTF2I/
NCF1 pseudogene locus, mapped on either side of the
deletion, in inverted orientation with respect to each
other (fig. 2). STS-content mapping of BAC clones con-
tiguous with both the GTF2I/NCF1 gene and pseudo-
gene loci disclosed the presence of discrete clusters of
sequence elements that occurred within and flanking the
WBS deletion. These elements are defined as REPs A,
AB, B1, B2, and C–E (fig. 1). The relative orientation
of these repeat clusters, where discernible, is indicated.
SSN assays of POM121 exons 2 and 3 in REP C and
of 23I15L and 68E13L in REP B1 allowed for the dis-
crimination of centromeric from telomeric duplicon
clones (table 6). Sequencing of amplimers unequivocally
placed BACs 112A9, 5C19, 93N13, 34N24, 155N21,
194I16, and 7H23 in one duplicon and BACs 171C15,
113E20, 163N16, and 496I13 in the other. HTGS anal-
ysis localized BACs 479C13 and 313P13with the former
group and 953A04 with the latter.
Sequence analysis of the 318-bp 269P13R (REP A)
amplimers, followed by comparison with HTGS data,
failed to discriminate between the duplicons (table 6).
The ACA and ACG paralotypes were both associated
with the centromeric duplicon and likely represent a
polymorphism. Larger products were amplified from
several clones because of variably present 20- and 50-
bp repeats within the amplimer. These were called
“269P13R-MID,” for the 340–380-bp products, and
“269P13R-LONG,” for the 460-bp products (fig. 1).
These longer 269P13R sequences were associated with
REP E, not with REP A. BAC 171C15 was established
as contiguous with the telomeric gene locus HIP1, by
the presence of 269P13R-LONG in common with HIP1
clones 204C11 and 16K14. Together, these data estab-
lished the 171C15/953A04 duplicon as telomeric and
the 194I16/313P13 duplicon as centromeric.
The Telomeric Duplicon: Incomplete Clone Coverage
The inverted telomeric duplicon contains a gap in
clone coverage, between the GTF2IP2/NCF1P2-carrying
BAC 447M6 and BACs 163N16, 113E20, and 496I13
(fig. 1). Genomic PFGE data predict the gap to be 80
kb. The absence of NotI sites on the telomeric duplicon
and contiguous HIP1-containing clones, as well as the
requirement that GTF2I/NCF1, GTF2IP2/NCF1P2, the
telomeric duplicon REPs A–E, and the HIP1 locus
all reside on the same 1-Mb fragment, suggests that the
140-kb PmeI and 320-kb AscI fragments occupied by
GTF2IP2/NCF1P2 are contiguous with the 210- or
220-kb PmeI and 380-kb AscI fragments carrying the
telomeric duplicon probes STAG3L, 17SP, and
POM121. Therefore, the genomic DNA–derived PFGE
map is essentially intact. Comparison with HTGS data
from centromeric flanking BACs 269P13 and 396K03
shows that the region of the centromeric duplicon that
corresponds to the gap in the telomeric duplicon contig
covers 60 kb; however, HTGS data in this region are
discontiguous for both clones.
Estimation of Size and Degree of Homology of the
Duplicons
The largest restriction fragments showing restriction-
site conservation between the centromeric and telomeric
duplicons are the 380-kb (REPS A and B) and 300- or
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320-kb (GTF2I/NCF1) AscI fragments, suggesting that
the duplication could be as large as 680 kb. Since the
former fragment contains at least one unique sequence
(i.e., HIP1) on the telomeric side, the duplicons must
be smaller than this estimated maximum. When the
proximal PmeI site of the centromeric POM121/17SP/
STAG3L duplicon fragment and the distal limit of the
NCF1P1 locus are used as boundaries, the duplicon size
is estimated at ∼320 kb. Analysis of HTGS data from
BACs 269P13, 396K03, and 313P13 predicts a size of
280 kb, although the sequences are discontiguous,
with several gaps.
For comparison, sequences of the overlapping 170 kb
from HTGS data for BACs 313P13 (centromeric dupli-
con) and 953A04 (telomeric duplicon) were assembled
around selected markers from each REP area and were
analyzed for their degree of identity. At REPs A and AB,
sequence differences were found at a frequency of 1–2/
1,000 bp. REP B1 sequence differences ranged from ∼5/
1,000, around FKBP6 ex1-4, to ∼12/1,000, at 68E13L;
POM121 ex11 in REP C demonstrated differences at
17/1,000, and the REP B2 loci 171C15L and 965F7L
differed at a frequency of ∼40/1,000. HTGS data
from the 120 kb of overlapping sequence of BACs
269P13/396K03 (GTF2IP1/NCF1P1) and 350L10/
239C10 (GTF2I/NCF1) also revealed a high level of
identity, with nucleotide differences of only 1–2/1,000.
Results of SSN assays in this region suggested the same
degree of identity between the GTF2IP1/NCF1P1 locus
and the GTF2IP2/NCF1P2 locus. Therefore, sequence
conservation is significantly higher near the GTF2I/
NCF1 repeats and falls off toward REP B2. Comparison
of sequence information for the centromeric duplicon
BAC 313P13 versus that for the intradeletion REP B
BAC 208H19 disclosed that homology between these
regions is substantially lower, with differences occurring
at frequencies from ∼20/1,000 bp, around 17SP (REP
AB), to 60/1,000, around 93N13L (REP B1).
Origin and Distribution of the REP Elements
The REP regions were first identified on the basis of
the presence of multiple loci, mapping within and im-
mediately flanking the deletion, that are recognized by
primers for D7S489. Our experimental data confirm that
the D7S489A locus maps just distal of GTF2I/NCF1,
whereas D7S489B maps proximally between FKBP6 and
FZD9. D7S489C-sized alleles of 156 and 158 bp are
amplified from clones in both the centromeric and telo-
meric duplicons. Thus, D7S489C is duplicated and can-
not serve to discriminate between the two duplicons.
D7S489ABC, along with a new, neighboring anonymous
marker, 17SP, form an unusual element, referred to here
as “REP AB.” Both sequences are found, by STS-content
mapping and by sequence analysis of HTGS clones,
close to the ancestral REP B1 element (D7S489B; BAC
68E13, etc.), between REPs A and B of the centromeric
and telomeric duplicon clones (D7S489C; BACs 194I16,
7H23, 313P13, etc.), and with REP A sequences only
(D7S489A; BAC 350L10, etc.). We assume that the
D7S489B/BAC 68E13 REP B1 locus is “ancestral” be-
cause it contains the complete FKBP6 gene, including
the 3′ exons 5–8 not otherwise associated with the du-
plicon REP B1 sequences, which contain only FKBP6
exons 1–4. Also, FKBP6 exon 4 overlaps the 23I15L
SSN-assay locus, matching the paralotype associated
with BACs 23I15 and 68E13 and distinguishing it from
the duplicon sequences (table 6). Interestingly, both
probe STAG3L and probe 17SP also hybridize weakly
to 200-kb NotI fragments in the SCHs DEL-1, DEL-2,
and NONDEL-2 hybrid lines but not in the SCH NON-
DEL-1. This result is consistent with the presence of a
STAG3L/17SP locus on 7q22, since the single chromo-
some 7 in the SCH NONDEL-1 has undergone a ter-
minal deletion distal to 7q11.23 (data not shown).
In figure 1, the REP B locus has been divided into
REPs B1 and B2 because of an intervening duplicated
element, called “REP C,” within the duplicon. This el-
ement has not been assayed by hybridization, because
we were unable to generate an effective probe from this
region. We have not ruled out the possibility that, in this
region, sequence homology between the ancestral REP
B locus and the duplicons is too low for reliable PCR
amplification. REP C is interesting, in that, with REP
B1, it contains sequences from the POM121 gene, which
is involved in another recombination event with the
chromosome 7 ZP3 gene (Kipersztok et al. 1995). HTGS
data available for BACs 340A14 and 1158B10 show
that they contain REP E sequences (sWSS3379; 763H7L
and 1158B01 only), REP A sequences (sWSS3380 and
435J21L), and the common unique paralotype ATA at
269P13R (table 6). These clones contain the ZP3 locus
and the POM121-ZP3 locus, respectively. Both genes
have previously been mapped to 7q11.23 (Kipersztok et
al. 1995). PFGE results with the ZP3-specific and
POM121-ZP3–specific probes revealed that these loci
are beyond the immediate WBS flanking region (data
not shown).
The Telomeric and Centromeric Deletion Breakpoints
In our WBS-deletion SCHs, the telomeric breakpoint
is defined by the presence of D7S489A and by the ab-
sence of GTF2I (fig. 1). These boundaries are consistent
with those in the majority of individuals with WBS, as
determined by assessment of a GTF2I/GTF2IP1 dosage-
sensitive, site-specific PCR-RFLP assay (Pe´rez-Jurado et
al. 1998) and by simple sequence tandem repeat (SSTR)
typing at D7S489A of informative families (Pe´rez-Jurado
et al. 1996; Wu et al. 1998). The telomeric breakpoint
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as determined by PFGE mapping falls between GTF2I/
NCF1 (deleted) and STAG3L/17SP (retained) (fig. 2).
At the centromeric breakpoint, the internal limit for
the common WBS deletion has previously been defined
by the absence of both the FZD9 gene (Wang et al. 1997)
and the SSTR locus AFMb055xe5 (Peoples et al. 1998).
These data have placed the centromeric breakpoint onto
or proximal to BAC 68E13. PFGE mapping with PmeI
has placed the centromeric breakpoint between the
centromeric GTF2IP1/NCF1P1 locus (retained) and
POM121 on BAC 68E13 (deleted) (fig. 2 and table 5).
Meng et al. (1998a) placed the centromeric breakpoint
on BAC 68E13 by use of FISH studies of WBS chromo-
somes. Recognizing that BAC 68E13 contains nonu-
nique sequences, making FISH-based determination of
deletion/nondeletion status unreliable, we looked for a
way to discriminate the 68E13 REP B sequence from
that of the extradeletion copies. By comparing HTGS
data from BACs 313P13 and 208H19, we designed an
SSN assay (208H19-M) incorporating several predicted
restriction-site differences for the two loci. Results of
SSN assays of BACs and SCHs indicate that the locus
defined by BACs 68E13, 23I15, and 208H19 is within
the deletion (fig. 4B).
By comparison with HTGS data from the homologous
REP B region of BAC 313P13, representing the cen-
tromeric duplicon, BAC 68E13 is predicted to contain
∼42 kb of REP B sequence; 208H19-Mmaps 37 kb from
the centromeric limit, at 68E13L. However, PFGE data
show that the 140-kb PmeI fragment containing the an-
cestral REP B1 locus of BAC 68E13, recognized by the
probe POM121, is not present in the SCHs retaining the
deleted chromosome 7. The PmeI junction fragment is
also absent, consistent with the complete deletion of this
locus on the WBS chromosome in the SCH lines. Se-
quence information obtained from the 5′ and 3′ ends of
cDNA 166272 containing POM121-ex13, compared
with BAC 313P13 HTGS data, shows that this cDNA
is predicted to match the homologous regions of BAC
68E13, at both ends. Furthermore, the 3′ sequence of
this cDNA is contiguous with the 68E13L sequence, con-
firming that it is homologous to the centromeric limit
of BAC 68E13. Therefore, PFGE hybridization results
are consistent with the centromeric breakpoint’s lying
proximal of BAC 68E13 but distal of the PmeI-site clus-
ter on the GTF2IP1/NCF1P1 BACs 91D18, 269P13, etc.
Discussion
Completion of the WBS deletion–region map has been
hampered by the presence of highly homologous regions,
flanking the deletion, within which the deletion break-
points cluster. Both accurate assessment of the deletion
size and definition of precise breakpoint sequences re-
quire the establishment of contiguous-clone coverage
across these regions. We have identified several site-spe-
cific sequence changes that have allowed us to precisely
map BACs to specific duplicons. Furthermore, by inte-
gration of long-range restriction-mapping data, we have
defined the presence of a second GTF2I/NCF1 pseu-
dogene cluster and have localized it within 1 Mb telo-
meric of the WBS deletion. Mapping reports confounded
by these three extremely similar duplicons have led to
confusion in the literature. The large-scale chromosome-
mapping efforts of the National Human Genome Re-
search Institute (Bouffard et al. 1997; Touchman et
al. 1997) and the Whitehead Institute Human Physical
Mapping Project (release 12; July, 1997) understandably
produced contigs that bounced back and forth across
the deletion, from one duplicon to the other.
In this report, we have presented detailed dissections
of the centromeric and telomeric duplicons flanking the
WBS deletion. Each duplicon is composed of one copy
each of a GTF2I/NCF1 pseudogene locus contiguous
with newly defined low-copy repeated regions, which
we have designated REPs “A,” “AB,” “B1,” “B2,” and
“C”–“E.” These duplicons extend over 1320 kb; are
inverted in orientation, relative to each other; and dem-
onstrate a high level of sequence identity, with only 1–2/
1,000 nucleotide differences at the GTF2I/NCF1, REP
A, and REP AB loci and with more sequence divergence
toward the distal elements of the duplicon. Hockenhull
et al. (1999) recognized the presence of a centromeric
duplicon with content similar to that of the duplicon
described here. However, they incorrectly placed the
telomeric BACs 113E20 and 163N16 in this duplicon.
They further reported their duplicon to be in opposite
orientation to ours, suggesting that they failed to dis-
criminate between the BACs containing the D7S489B
and C loci.
Some of the duplicon repeat elements are found in
association with the telomeric GTF2I/NCF1 (REPs A,
AB, and D) site, which contains the functional loci and
is considered to be the ancestral locus of the GTF2IP1/
NCF1P1 and GTF2IP2/NCF1P2 pseudogene-containing
duplicons. In turn, REPs B1 and B2—associated with
FKBP6 on BACs 68E13, 208H19, and 23I15 within the
common deletion—represent the ancestral locus for
these repeat regions within the duplicons. The origin of
the AB elements found in proximity to each ancestral
locus is unclear; however, PFGE data provide additional
evidence of homology to a non-7q11.23 site. Previous
reports suggested that REP A sequences PMS2L and
STAG3L may not have originated as part of the WBS
region at 7q11.23 but that they may be part of a du-
plication derived from the 7q22 region, which, in hu-
mans, has some homology with the WBS-region repeats
(Osborne et al. 1997a; DeSilva et al. 1999; L. Pe´rez-
Jurado, personal communication). It is possible that REP
AB is derived from an ancient inversion event that
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brought 7q11.23 and 7q22 sequences together, the rem-
nants of which are found today as paralogous sequences
at both loci. Such inversions were shown, by DeSilva et
al. (1999) for gorilla and orangutan. In addition, we
present evidence for a smaller inversion event, compris-
ing the WBS-deletion region only, relative to the con-
served syntenic region on mouse chromosome 5. We
have localized HIP1 to the telomeric side of the WBS-
deletion region, whereas, in the mouse, Hip1 is found
near Fzd9 and Wbscr9 (Wang et al. 1999; L. Pe´rez-
Jurado, personal communication).
Within the flanking duplicons, the POM121 gene was
identified and the low-copy REP elements A and E were
defined. Each of these elements is found in BACs con-
taining the POM121-ZP3 fusion gene, whereas the A
and B elements are found with the (presumably ances-
tral) ZP3 locus. Whereas the ZP3 and POM121-ZP3
loci have not been precisely mapped relative to the de-
letion, both have been localized to 7q11.23. These re-
sults provide further evidence for both the mobile nature
of these sequence elements on chromosome 7—that is,
they can be present beyond the WBS-deletion re-
gion—and the complexity of their distribution.
The duplicated regions were first defined by the SSTR
D7S489, whose primers generate amplimers from at
least three loci designated as “A”–“C” (Pe´rez-Jurado et
al. 1996). BACs from which D7S489C-sized alleles can
be amplified have, by some groups, been mapped cen-
tromeric to the deletion (Pe´rez-Jurado et al. 1996; Os-
borne et al. 1997a), whereas others (Robinson et al.
1996) have placed this locus on the telomeric side. We
found D7S489C in both duplicons. One question that
remains unanswered is why the D7S489C loci amplify
so weakly from genomic DNA, compared with the
D7S489A and B loci. On the basis of HTGS data, the
A- and C-locus primer-site sequences are identical to
those of the primers used for PCR, whereas the B locus
has a single mismatch in the reverse primer yet is am-
plified much more strongly than either of the C loci.
Our previous report on GTF2I incorrectly identified
D7S489B as part of the centromeric repeat (Pe´rez-Jurado
et al. 1998). We now understand that D7S489B is part
of the ancestral REP AB locus and not a part of the
complete duplication that is contiguous with GTF2I/
NCF1 sequences. This finding is in disagreement with
the map presented by Osborne et al. (1997a), which
identifies two complete copies of the repeat on the cen-
tromeric side of the deletion that are in association with
D7S489B.
Our map places each of the centromeric GTF2IP1/
NCF1P1, REP A, and REP D loci in the same orientation
as the telomeric GTF2I/NCF1 and contiguous REP loci.
Since the telomeric breakpoints cluster between the
GTF2I/NCF1 locus and the telomeric REP AB sequence
D7S489A, the common WBS deletion results from non-
homologous recombination between the GTF2I/NCF1
locus and the GTF2IP1/NCF1P1 locus. Our inability to
detect novel junction fragments with GTF2I and NCF1
probes reflects the strong conservation of restriction sites
over the 150–200-kb GTF2I/NCF1 loci. Breakpoint het-
erogeneity on the telomeric side is suggested by rareWBS
cases reported to be hemizygous at D7S489A (Wang
et al. 1998a). In these cases, an intrachromosomal
exchange may have occurred between the centromeric
GTF2IP1/NCF1 duplicon and the telomeric GTF2IP2/
NCF1P2 duplicon.
Go¨rlach et al. (1997) identified the common NCF1
mutation leading to autosomal chronic granulomatous
disease (CGD [MIM 233700]) as being a potential gene
conversion between the NCF1 gene and a pseudogene.
Carriers of this mutation should be investigated for pos-
sible recombination between the NCF1 locus and the
telomeric pseudogene NCF1P2 locus. On our map, these
loci are in opposite orientation to each other, requiring
the consideration of models other than simple nonhomo-
logous crossover events. Patients with WBS with
D7S489A deletions do not have more-severe phenotypic
findings, consistent with the absence, in individuals het-
ero- and homozygous for the NCF1 del GT mutation
resulting from such a recombination, of pathology be-
yond CGD. The substantially stronger degree of ho-
mology demonstrated among the loci GTF2I/NCF1,
REP A, and REP D—as opposed that among to the REP
B, C, and E loci—may reflect frequent conversion events
preserving homology among the former, which do not
occur for the latter.
Our model placing the common centromeric break-
point at the centromeric GTF2IP1/NCF1P1 locus dis-
agrees with the report by Meng et al. (1998a), who, by
use of FISH studies of patients with WBS, mapped the
proximal breakpoint on BAC 68E13. We determined,
by use of PFGE blot hybridization with the POM121
probe, that the centromeric breakpoint is proximal to
BAC 68E13. This BAC contains ∼50 kb of REP element
B1 that is also present in both flanking regions outside
the deletion. Therefore, FISH studies with this BAC as
the probe should be inconclusive.
Duplicon-mediated microscopic and submicroscopic
deletions are a relatively common accident of human
reproduction. In velo-cardio-facial syndrome (VCFS
[MIM 192430]), a 3-Mb deletion in 22q11 is bounded
by ∼200-kb duplicons within which the common break-
points cluster (Edelmann et al. 1999a, 1999b). As de-
scribed here for the WBS region, the VCFS repeats are
also nearly identical with conservation of restriction
sites. The Smith-Magenis syndrome (SMS [MIM
182290]) deletion at 17p11.2 is also mediated by non-
homologous recombination at duplicons of ∼200 kb
(Chen et al. 1997). The SMS region shares with WBS
the presence of a third copy of the repeat, which does
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not participate in the typical recombination errors. The
Prader-Willi syndrome (PWS [MIM 176270])/Angelman
syndrome (AS [MIM 105830]) region at 15q11-13 con-
tains at least three to five copies of a 50–200-kb tran-
scriptionally active repeat unit, which serve as foci for
the nonhomologous recombination events leading to
the common PWS/AS deletions (Amos-Landgraf et al.
1999). Other examples of duplicons associated with
chromosomal deletions and/or duplications include the
Charcot-Marie-Tooth 1A/hereditary neuropathy with li-
ability to pressure palsies (HNPP [MIM 162500]) re-
gion, also at 17p11.2-13, and the spinal muscular at-
rophy types 1-3 (SMAI, II, and III [MIM 253300, MIM
253550, and MIM 253400]) locus at 5q11-13 (Eichler
1998; Lupski 1998; Mazzarella and Schlessinger 1998).
Although the map presented here of the WBS-deletion
region and the flanking duplicons is not entirely com-
plete, it is, to date, the most comprehensive. The BAC
contig covering the unique deleted region is complete
and should enable the identification of all functional
genes that are lost by the deletion formation. Further
work should compare the sequence of the telomeric
GTF2IP2/NCF1P2 locus with those of the gene and the
centromeric pseudogene loci. Placement of BACs into
accurate contigs should accelerate the assembly of con-
tiguous sequence generated by the high-throughput ge-
nome-sequencing project.
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